METHODS

Patient ascertainment and clinical examination:
After receiving ethical approval from the institutional review board (IRB#00006862; All India Institute of Medical Sciences, Delhi, India), 100 clinically diagnosed congenital cataract cases from northern India who presented at the Dr. R. P. Centre for Ophthalmic Sciences (AIIMS, New Delhi, India) were enrolled in this study. In this study 69% of the patients were found to male as compared to 31% female. Mean age of the patients is 17.45±16.51 and the mean age of onset of disease was 1.618±0.7181. Affected status was determined by a history of cataract extraction or ophthalmologic examination. A total of 100 normal individuals without any history of ocular disorders were enrolled as controls. Patients with a history of intrauterine infection such as rubella, TORCHES (TOxoplasmosis, Rubella, Cytomegalovirus, HErpes simplex, Syphilis), and traumatic cataract were excluded from the study. Informed consent in accordance with the Declaration of Helsinki was obtained from all participants or their parents.
Polymerase chain reaction and deoxyribonucleic acid sequencing: Brief description for how the blood was drawn and how samples were preserved prior to use is as follow: For DNA isolation 2-3 ml of peripheral blood was collected in EDTA vials from each case. The samples were stored in -80 °C prior to use. Genomic DNA was extracted from the blood samples of the patients with congenital cataract and controls, using an organic method described by Sambrook et al. [22] . The exon-intron regions of all the genes (CRYAA, CRYAB, CRYGs, CRYBA1, CRYBA4, CRYBB1, CRYBB2, CRYBB3, BFSP1, GJA3, GJA8, and HSF4) were amplified. PCR amplifications for all primer sets (Table 1) were performed in a 40 μl volume containing 1.0 μl of 20 mM stock solution for each primer (Eurofins Genomics India, Bangalore, India), 100 ng genomic DNA, 1 unit Taq polymerase (Banglore Genei, Bengaluru, India), 0.1 mM each deoxynucleotide triphosphate (dNTP), and 4 μl 10X PCR buffer (with 15 mM MgCl 2 ). Amplified PCR products were purified using a gel/PCR DNA fragments extraction kit (Geneaid Biotech, Sijhih City, Taiwan). Purified PCR products were sent for sequencing to Molecular Cloning Laboratories (South San Francisco, CA). All sequence variants were compared to the Human Genome Reference Sequence provided by the National Center for Biotechnology Information (NCBI), using ClustalW2 (multiple sequence alignment program for DNA; European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK).
Bioinformatics analysis:
MutationTaster, a free, webbased application was used for rapid evaluation of the disease-causing potential of DNA sequence alterations [23] . The Sorting Intolerant From Tolerant (SIFT) analysis tool was also used to predict the functional impact of the missense changes identified in this study [24] . Positions with normalized probabilities <0.05 are predicted to be deleterious, and those ≥0.05 are predicted to be tolerated. Another free, webbased application, PolyPhen-2, structurally analyzes an amino acid polymorphism and predicts whether that amino acid change is likely to be deleterious to protein function [25, 26] . A PolyPhen-2 score of >2.0 indicates the change is probably damaging to protein function. Scores of 1.5-2.0 are possibly damaging, and scores of <1.5 are likely benign. Three webbased applications were used to predict the pathogenicity of non-synonymous variations. The variations were considered pathogenic only when the outcome of two out of three applications suggested the variations were disease causing.
Protein modeling:
The normal and mutant proteins were analyzed for their structure. Prediction of structure differences between the wild-type and mutant proteins was performed using Discovery Studio (DS) 2.0 (Accelrys, San Diego, CA) [27] . The first step in the homology modeling method is to find a suitable homologous structure (template). Thus, structural differences between the wild-type and mutant were predicted in mutants when a suitable template or homolog structure was present. The model structure of the three mutant proteins was developed and refined with minimization programs in the presence of the CHARMm force field in a manner similar to the structure of the A4 protein.
Statistical analysis: Pearson χ
2 /Fisher's exact test was applied to compare the two groups (cases versus controls). P values less than 0.05 were considered significant. All tests were performed with SPSS software for Windows (version 11.5; SPSS Inc., Chicago, IL).
RESULTS AND DISCUSSION
A total of 100 patients with sporadic congenital cataract were enrolled in this study. The age range of the patients was 1 month to 3 years. The mean age of onset was 1.618±0.7181 months, as the age at which the disease was first noticed by the child's parents or by a clinician. Out of 100 patients, 80 had bilateral congenital cataract, and 20 had unilateral congenital cataract. All cases enrolled were sporadic, and the male to female ratio was 2.2:1 (69 men and 31 women). Different forms of cataracts with variable degrees of opacification were observed. Nuclear cataract (72%) was the most prevalent phenotype found. The other phenotypes observed were zonular with nuclear (19%), total cataract (05%), Zonular/lamellar (03%) and anterior polar cataract (01%). 
Mutations in more than 40 genetic loci have been linked to congenital cataracts. Of these mutations, approximately half involve crystallins, one-quarter involve connexins, and the remaining involve other genes [9] . Direct sequencing analysis of 14 genes (CRYAA, CRYAB, CRYGs, CRYBA1, CRYBA4, CRYBB1, CRYBB2, CRYBB3, BFSP1, GJA3, GJA8, and HSF4) identified 18 nucleotide variations ( Functional changes in crystallin molecular properties could cause the breakdown of the lens microstructure and result in changes in the refractive index and increased light scattering [28] . Out of the 14 variations observed in the crystallin genes (Table 2) , eight were observed in the CRYBA4 gene, four in the CRYBB1 gene, and two in the CRYBB2 gene. Billingsley et al. [29] identified CRYBA4 as a cataract gene in a large Indian family with an autosomal dominant cataract phenotype. A total of 102 nucleotide variations (Table   3 ) have been reported in the CRYBA4 gene, but only three have been associated with cataract [30] (Table 4) . Two nonsynonymous, novel variations (CRYBA4:p.T84A, CRYBA4:p. Y67N) were found in exon 4 of the CRYBA4 gene. Computational assessment showed CRYBA4:p.Y67N was pathogenic whereas CRYBA4:p.T84A was polymorphic. CRYBA4:p.Y67N was found in two cases affected with bilateral nuclear cataract whereas CRYBA4:p.T84A was found in four patients. Two had zonular cataract, and two had nuclear cataract. None of the variations (CRYBA4:p.T84A, CRYBA4:p.Y67N) were found in the controls. The mutation CRYBA4:p.Y67N located in the neighboring β strand of the N-terminal domain whereas the CRYBA4:p.T84A mutation is situated in the β crystallin A4 protein in the loop region.
For modeling studies, the crystal structure of the human CRYBA4 protein (PDB id: 3LWK) was used as the template. The complete model structure including the missing region of the native human crystallin βA4 as well as its mutant (CRYBA4:p.T84A, CRYBA4:p.Y67N) were developed using the homology modeling approach to study the effect of the mutations on the crystallin's structure and function. The CRYBA4 protein model structure is dominated by β strands. The two domains interact through intramolecular contacts by the Build Mutant protocol, and the mutant was refined similarly to the wild-type protein structure.
The mutation CRYBA4:p.Y67N does not affect the conformation of the region housing the mutation (Figure 3) . Tyrosine (Tyr) is larger and more hydrophobic than Asparagine (Asn). Thus, the bulky Tyr67 side chain restricts the (Figure 4a ). These interactions serve as a bridge between the two domains. The substitution of the hydrophobic Alanine (Ala) to Threonine (Thr) disrupts the intramolecular hydrogen bond, which reduces the interdomain contact region as the Ala side chain is incapable of forming hydrogen bonds ( Figure 4B) . A slight broadening of the loop is also observed as the Asn83-mediated interactions are still conserved ( Figure 4A,B) . Thus, the mutation can lead to changes in the conformation of protein and its interaction with other partner proteins.
CRYBB1 is a major subunit of the β-crystallins and comprises 9% of the total soluble crystallin in the human lens [31] . A total of 42 nucleotide changes have been reported (Table 3) . Of these, seven have been associated with congenital cataract [30] (Table 4) . In this study, we detected four nucleotide variations (CRYBB1:p.D85N, CRYBB1:p.E75K, CRYBB1:p.E155K, and CRYBB1:rs57400078) in the CRYBB1 gene. Three novel variations (CRYBB1:p.D85N, CRYBB1:p. E75K, and CRYBB1:p.E155K) were pathogenic according to the in silico analysis (Table 3) . Most of the reported CRYBB1 gene mutations occur in exon 6 (Table 4) [30] , which encodes the Greek key IV and the COOH-terminal arm [32, 33] . The CRYBB1:p.D85N and CRYBB1:p.E75K variations were found in the same patient with nuclear form of cataract whereas the CRYBB1:p.E155K change was detected in seven cases with different cataract morphology. The CRYBB2 gene is one of the most important genes for lens transparency. We identified two novel variations (CRYBB2:p.D4N, CRYBB2:p.Q6Q) in the CRYBB2 gene. The non-synonymous, novel change (CRYBB2:p.D4N) was found in one patient with lamellar cataract.
The crystal structure of the human CRYBB1 protein (PDB ID: 1OKI) [34] was used as the template. The overall folds of CRYBB1 and CRYBA4 are similar ( Figure 5 ) except in the loop region. The N-terminal domain of the CRYBB1 protein harbors mutations (CRYBB1:p.E75K and CRYBB1:p. D85N) whereas CRYBB1:p.E155K occurs on the C-terminal domain. Both mutations are present on the surface of the protein ( Figure 5 ) and are thus exposed to solvents and would be engaged in protein-protein interactions. The Glu75 (an acidic residue), a component of the β strand, is positioned to make two hydrogen bonds with the guanidine group of Arg60 present on the adjacent antiparallel β strand in the wild-type protein ( Figure 6A ). The mutation CRYBB1:p.E75K alters the environment and charge on the protein surface, disrupting the ionic interaction between Glu75 and Arg60 ( Figure 6B) . Thus, CRYBB1:p.E75K changes the electrostatic potential of the protein surface, which could affect interactions with other interacting partner proteins.
The other change (CRYBB1:p.D85N) occurs in the single turn helix conformation of the CRYBB1 protein. Asp85 is involved in hydrogen bonding with the amide nitrogen of the Asn82 side chain present on the adjacent loop ( Figure 7A ). Aspartate (Asp) and Asn differ only in the side chain group, with a carboxyl group in the former and an amide in the latter. Thus, in the CRYBB1:p.D85N mutant, the hydrogen bondmediated interaction is retained ( Figure 7B ). In the other mutation (CRYBB1:p.E155K) in the CRYBB1 protein, Glu155, located on a surface loop, forms two hydrogen bonds, one with the side chain amide nitrogen and the other with the main chain nitrogen of Asn162 present on the same loop ( Figure  8A ). Since the change occurs on the protein surface, the elongated side chain does not perturb the protein conformation. However, to accommodate the change and impart stability to the loop, the amide group of Asn162 flips by approximately 180°. This results in the formation of a hydrogen bond with the side chain nitrogen atom of the mutated residue Lys155 ( Figure 8B ). The change in negatively charged Glu155 with positively charged Lys155 affects the electrostatic potential of the surface, which could be vital for binding with other interacting partners. Thus, the modeling studies indicate that the mutation in the CRYBA4 and CRYBB1 proteins alters the internal conformation of the protein and reduces the stability of the proteins. Thus, the observed mutations could affect the function of the protein, including its ability to bind to its interacting partners.
The eye lens is an avascular structure, and intercellular transport of small biomolecules (<1 kDa) is mediated through connexins (Cx) that encode gap junction channel proteins [35, 36] . GJA3 encodes a protein containing 435 amino acids and is present in specialized lens fibers, which constitute the majority of the lens [37] . Similar to other connexin proteins, connexin 46 (Cx46) consists of four transmembrane domains (TM1-TM4), two extracellular loops (E1 and E2), a cytoplasmic loop (CL) between TM2 and TM3, and cytoplasmic N-terminal (NT) and C-terminal (CT) domains [38] . We detected a non-synonymous variation GJA3:p.M1V, resulting in the formation of a truncated protein, which leads to opacification in the lens. We found this variation in a patient with anterior polar cataract but not in any of the controls.
BFSP1 and BFSP2 are highly expressed intermediate filaments and when mutated can cause cataract [39] . A total of 339 variations (Table 3) have been reported in BFSP1, but only one has been associated with an autosomal recessive mutation arising from a consanguineous marriage [40] ( Table 4) [30] . We detected three nucleotide variations, two of which were novel and non-synonymous (BFSP1:p.D395N, BFSP1:p.E424K); the other one (BFSP1:p.L44L) is reported. None of the mutations were pathogenic. Modeling studies of (A and B) , the interaction of residues as balls and sticks and hydrogen bonds as black dotted lines in beta crystallin B1 protein is same. the non-synonymous changes were not possible due to the lack of a suitable homolog model. The chi-square test and Fisher's exact test were used to compare differences in the frequency of the sequence variants, between the controls and individuals with congenital cataract. Chi-square analysis and Fisher's exact tests did not show any significant difference between the groups for any of the sequence variants. This study identified variations in 100 patients with congenital cataract in a northern Indian population. Pathogenic changes in the crystallin family accounts for 10% of the population whereas a study in southern Indian patients with congenital cataract [41] reported only 16.6% variations in the crystallin family. Connexins account for 1% of the population compared to the 5.5% reported by the earlier study [41] . Five variations (CRYBA4:p.Y67N, CRYBB1:p.D85N, CRYBB1:E75K, CRYBB1:E155K, GJA3:p.M1V) detected in this study are predicted to cause cataract. This study further confirms that the crystallin beta cluster on chromosome 22, GJA3, and BFSP1 plays a major role in maintaining lens transparency. The disease showed marked clinical and genetics (locus and allelic) heterogeneity. This study also expands the mutation spectrum of the genes associated with congenital cataract. Other genes might be involved in the growth, development, differentiation, and maintenance of lens transparency.
The study of genes related to congenital cataract and knowledge about the molecular mechanisms of their origin, in the near future, could be extended to age-related cataracts, which remain the leading cause of blindness worldwide. The accumulation of information about the physiology of the lens and the factors associated with the formation of senile cataracts acquired through genetic studies of congenital hereditary form could lead to new treatments and techniques to prevent different forms of cataract. 
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